News

91 tracked developments across 12 disease areas, 14-18 September 2026: approvals, late-stage data, deals and pipeline changes, each with what it means for the competitive landscape.

Read article →

News roundup

Biopharma News Round Up

7–11th September

This week's biopharma news was led by oncology readouts, regulatory momentum in rare disease, and a handful of notable pipeline setbacks.

Read article →

News roundup

Biopharma News Round Up

1–7 September

Approvals, Phase 3 Inflection Points, and Cell-Therapy Safety Signals

Read article →

Track these moves as they happen, not a week later.

Get early access